DIRECT MEASUREMENT OF PROPRANOLOL BIOAVAILABILITY DURING ACCUMULATION TO STEADY-STATE

被引:152
作者
WOOD, AJJ [1 ]
CARR, K [1 ]
VESTAL, RE [1 ]
BELCHER, S [1 ]
WILKINSON, GR [1 ]
SHAND, DG [1 ]
机构
[1] VANDERBILT UNIV,SCH MED,DIV CLIN PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.1111/j.1365-2125.1978.tb00862.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:345 / 350
页数:6
相关论文
共 11 条
[1]   SENSITIVE GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF PROPRANOLOL IN HUMAN PLASMA [J].
DISALLE, E ;
BAKER, KM ;
BAREGGI, SR ;
WATKINS, WD ;
CHIDSEY, CA ;
FRIGERIO, A ;
MORSELLI, PL .
JOURNAL OF CHROMATOGRAPHY, 1973, 84 (02) :347-353
[2]  
EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[3]   CONTRIBUTION OF LIVER TO OVERALL ELIMINATION OF PROPRANOLOL [J].
GEORGE, CF ;
ORME, MLE ;
BURANAPONG, P ;
MACERLEAN, D ;
BRECKENRIDGE, AM ;
DOLLERY, CT .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (01) :17-27
[4]   RATE OF ELIMINATION OF TRACER DOSES OF PHENYTOIN AT DIFFERENT STEADY-STATE SERUM PHENYTOIN CONCENTRATIONS IN EPILEPTIC PATIENTS [J].
HOUGHTON, GW ;
RICHENS, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) :155-161
[5]  
NIES AS, 1973, J PHARMACOL EXP THER, V184, P716
[6]  
PATERSON J W, 1970, Pharmacologia Clinica, V2, P127, DOI 10.1007/BF00420338
[7]  
PESSAYRE D, GASTROENTEROLOGY
[8]   CLEARANCE CONCEPTS IN PHARMACOKINETICS [J].
ROWLAND, M ;
BENET, LZ ;
GRAHAM, GG .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02) :123-136
[9]  
SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112
[10]   GLC DETERMINATION OF PROPRANOLOL, OTHER BETA-BLOCKING DRUGS, AND METABOLITES IN BIOLOGICAL-FLUIDS AND TISSUES [J].
WALLE, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (12) :1885-1891